IL17A and inflammatory bowel disease: Hovhannisyan et al. observed the increased levels of IL-17A in serum and mucosa of CD patients, what underline the role of excessive activation Th17 lymphocyte pathway dependent on IL-23 in the pathogenesis of IBD [13, 14].